What Is (+)-beta-caryophyllene synthase
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 10, 2026
Key Facts
- Beta-caryophyllene comprises 3.8–37.5% of cannabis flower essential oil and is produced by the CsTPS9 gene in all cannabis cultivars
- The enzyme catalyzes a complex intramolecular cyclization reaction that converts farnesyl diphosphate (C15) through humulyl and caryophyllyl cation intermediates
- Engineered E. coli strains carrying the TPS7 gene from tobacco achieved 5,142 mg/L beta-caryophyllene production through fed-batch fermentation
- Beta-caryophyllene is a selective CB2 receptor agonist with non-psychogenic properties, unlike CB1-binding cannabinoids in cannabis
- The enzyme localizes in the cytosol as a terpene synthase with 550–850 amino acids typical of the sesquiterpene synthase family
Overview
Beta-caryophyllene synthase (EC 4.2.3.89) is a critical enzyme in plant secondary metabolism that catalyzes the biosynthesis of beta-caryophyllene, a bicyclic sesquiterpene with significant agricultural, pharmaceutical, and industrial applications. This enzyme belongs to the terpene synthase family, a group of approximately 200 known enzymes responsible for producing diverse volatile organic compounds found throughout the plant kingdom. The enzyme consists of approximately 550 amino acid residues and has a predicted molecular mass of 63.99 kDa, placing it within the typical size range for sesquiterpene synthases (50–100 kDa).
Beta-caryophyllene itself is one of the most abundant terpenes in nature, found at concentrations ranging from 3.8–37.5% in cannabis flower essential oil, making it a dominant aromatic compound in certain cultivars. The enzyme is expressed in diverse plant species including cannabis sativa, Zanthoxylum piperitum (Japanese pepper), tobacco, hops, and cotton, where it functions as a key catalyst in the mevalonate (MVA) and methylerythritol phosphate (MEP) biosynthetic pathways. Unlike many other plant volatiles, beta-caryophyllene acts as a phytocannabinoid that selectively activates CB2 receptors, providing therapeutic potential without the psychogenic effects associated with CB1-binding cannabinoids.
How It Works
The enzymatic mechanism of beta-caryophyllene synthase involves a sophisticated multi-step catalytic process that transforms the common C15 isoprenoid precursor farnesyl diphosphate into a complex bicyclic product:
- Substrate Binding and Activation: Farnesyl diphosphate (FPP), the universal C15 sesquiterpene precursor, binds to the enzyme's active site in the cytosol. FPP is generated upstream through the sequential condensation of one dimethylallyl pyrophosphate (DMAPP) and two isopentenyl pyrophosphate (IPP) molecules by farnesyl diphosphate synthase.
- Ionization and Cyclization: The enzyme catalyzes the ionization of the FPP diphosphate group, generating a highly reactive allylic carbocation. This activated intermediate undergoes intramolecular cyclization through nucleophilic attack of distal double bonds, forming an initial cyclized cation intermediate known as the humulyl cation.
- Carbocation Rearrangement: The humulyl cation undergoes a series of 1,2-hydride and methyl shifts, a process called carbocation rearrangement, to form the caryophyllyl cation. These rearrangements are crucial for establishing the final bicyclic ring system characteristic of beta-caryophyllene.
- Deprotonation and Product Release: A conserved tyrosine or serine residue in the enzyme's active site facilitates deprotonation of the caryophyllyl cation, releasing the neutral beta-caryophyllene product. The enzyme then regenerates its active site for additional catalytic cycles.
- Structural Specificity: The enzyme's precise active site geometry controls which regioisomers and stereoisomers are produced. In cannabis, the CsTPS9 gene specifically encodes both beta-caryophyllene and alpha-humulene synthase activities, though beta-caryophyllene is the predominant product.
Key Comparisons
| Feature | Beta-Caryophyllene Synthase | Alpha-Pinene Synthase | Limonene Synthase |
|---|---|---|---|
| Substrate | Farnesyl diphosphate (C15) | Geranyl diphosphate (C10) | Geranyl diphosphate (C10) |
| Product Type | Bicyclic sesquiterpene | Bicyclic monoterpene | Monocyclic monoterpene |
| Molecular Mass (kDa) | ~63.99 | ~35–40 | ~35–40 |
| Localization | Cytosol | Plastid/Chloroplast | Plastid/Chloroplast |
| Industrial Production | 5,142 mg/L (engineered E. coli) | ~3,000 mg/L (engineered systems) | ~4,500 mg/L (engineered systems) |
| Plant Distribution | Cannabis, hops, pepper, cotton | Pine, rosemary, conifer trees | Citrus fruits, mint, caraway |
Why It Matters
- Pharmaceutical Applications: Beta-caryophyllene acts as a dietary cannabinoid and selective CB2 receptor agonist, providing anti-inflammatory, analgesic, and immunomodulatory properties without CB1-mediated psychoactivity. This makes beta-caryophyllene synthase a target for therapeutic compound production in both plant cultivation and synthetic biology systems.
- Biotechnological Engineering: Recent advances in enzyme engineering and synthetic biology have dramatically improved beta-caryophyllene production efficiency. Engineered E. coli strains carrying the tobacco TPS7 beta-caryophyllene synthase gene achieved 5,142 mg/L production through fed-batch fermentation, making microbial fermentation a viable alternative to plant extraction for meeting industrial demand.
- Flavor and Fragrance Industry: Beta-caryophyllene is widely used in the food, cosmetic, and fragrance industries due to its spicy, warm, woody aroma. Its enzymatic synthesis enables sustainable, scalable production of this valuable flavor compound without reliance on seasonal plant harvests or regional agricultural limitations.
- Natural Product Chemistry: Understanding beta-caryophyllene synthase mechanism has advanced the broader field of terpene chemistry, revealing how plants engineer complex molecular architectures through multi-step enzymatic processes. This knowledge informs strategies for metabolic engineering of other valuable secondary metabolites.
The enzyme remains a central focus in plant genetics, synthetic biology, and biotechnology research, with ongoing efforts to identify novel variants with enhanced catalytic efficiency, alternative substrate specificity, or improved expression characteristics. As pharmaceutical interest in non-intoxicating cannabinoids continues to grow and flavor compound demand increases globally, beta-caryophyllene synthase will likely become an increasingly important target for enzyme engineering and industrial-scale bioproduction systems.
More What Is in Daily Life
Also in Daily Life
More "What Is" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
- Wikipedia: (+)-beta-caryophyllene synthaseCC-BY-SA-4.0
- BRENDA Enzyme Database: (-)-beta-caryophyllene synthase (EC 4.2.3.57)Open Access
- Terpene Synthases and Terpene Variation in Cannabis sativa - Plant PhysiologyOpen Access
- Highly efficient biosynthesis of β-caryophyllene with a new sesquiterpene synthase from tobaccoCC-BY-4.0
- Beta-caryophyllene is a dietary cannabinoid - PNASPublic Domain
Missing an answer?
Suggest a question and we'll generate an answer for it.